Company intelligence / Profile preview

Cronus Pharma

East Brunswick, New Jersey, United Statescronuspharmausa.com ↗

Ownership: Private
Development stage: Other

Overview

Cronus Pharma is focused on commercialized generic pharmaceuticals for animal health. They have over 50 approved products with at least 11 actively marketed across companion animals, equine, and food-producing animal segments. Their business model centers on providing cost-effective alternatives to branded drugs that have yet to be genericized in the US market.

Therapeutic areas: NephrologyNeurologyInfectious Diseases
Modalities: Small moleculeCephalosporinSterile injectablesSolid oral dose forms
Industry: Veterinary

Partnerships

Partnerships with top API producers and CMOs globallynational/regional distributors

Beyond the preview

Go deeper on Cronus Pharma.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cronus Pharma.